Case Consult: 62-Year-Old Woman With Obesity and Type 2 Diabetes

Target Audience
This activity has been designed to address the educational needs of cardiologists and primary care physicians, including lipid specialists, internists, family physicians, pharmacists, nurses, nurse practitioners, and PAs.

Program Overview
This case consult will examine the differences in characteristics and clinical profiles of new and emerging nonstatin LDL-C-lowering agents.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Identify patients taking statins who may benefit from additional low-density lipoprotein cholesterol (LDL-C)–lowering interventions
Distinguish among current and emerging nonstatin LDL-C therapies based on unique characteristics and clinical profiles
Develop evidence-based treatment plans for at-risk patients who require additional lowering of LDL-C levels beyond statin therapy, considering patient preferences and accessibility/coverage
Discuss strategies to improve the knowledge, skills, or performance of the healthcare team